questionsmedicales.fr
Facteurs biologiques
Pigments biologiques
Porphyrines
Uroporphyrines
Uroporphyrines : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Uroporphyrines : Questions médicales les plus fréquentes",
"headline": "Uroporphyrines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Uroporphyrines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-01",
"dateModified": "2025-03-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Uroporphyrines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Porphyrines",
"url": "https://questionsmedicales.fr/mesh/D011166",
"about": {
"@type": "MedicalCondition",
"name": "Porphyrines",
"code": {
"@type": "MedicalCode",
"code": "D011166",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Uroporphyrines",
"alternateName": "Uroporphyrins",
"code": {
"@type": "MedicalCode",
"code": "D014578",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Juliana Bragazzi Cunha",
"url": "https://questionsmedicales.fr/author/Juliana%20Bragazzi%20Cunha",
"affiliation": {
"@type": "Organization",
"name": "Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, 08854, USA. bragazzi@umich.edu."
}
},
{
"@type": "Person",
"name": "Jared S Elenbaas",
"url": "https://questionsmedicales.fr/author/Jared%20S%20Elenbaas",
"affiliation": {
"@type": "Organization",
"name": "Medical Scientist Training Program, Washington University, Saint Louis, 63110, USA."
}
},
{
"@type": "Person",
"name": "Dhiman Maitra",
"url": "https://questionsmedicales.fr/author/Dhiman%20Maitra",
"affiliation": {
"@type": "Organization",
"name": "Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, 08854, USA."
}
},
{
"@type": "Person",
"name": "Ning Kuo",
"url": "https://questionsmedicales.fr/author/Ning%20Kuo",
"affiliation": {
"@type": "Organization",
"name": "Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, 08854, USA."
}
},
{
"@type": "Person",
"name": "Rodrigo Azuero-Dajud",
"url": "https://questionsmedicales.fr/author/Rodrigo%20Azuero-Dajud",
"affiliation": {
"@type": "Organization",
"name": "Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, 08854, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Ensuring environmental inclusion in developing countries: the role of macroeconomic policies.",
"datePublished": "2022-12-07",
"url": "https://questionsmedicales.fr/article/36474034",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11356-022-24596-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluating the quality of health technology assessment reports in a developing country.",
"datePublished": "2023-07-31",
"url": "https://questionsmedicales.fr/article/37553743",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.26719/emhj.22.017"
}
},
{
"@type": "ScholarlyArticle",
"name": "Investigating the impact of air pollution in selected African developing countries.",
"datePublished": "2023-04-17",
"url": "https://questionsmedicales.fr/article/37067712",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11356-023-26998-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "The national health program for vitamin D supplementation in a developing country.",
"datePublished": "2023-01-20",
"url": "https://questionsmedicales.fr/article/36963898",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clnesp.2023.01.012"
}
},
{
"@type": "ScholarlyArticle",
"name": "Addressing vaccine hesitancy in developing countries: Survey and experimental evidence.",
"datePublished": "2022-11-17",
"url": "https://questionsmedicales.fr/article/36395260",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0277493"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Pigments biologiques",
"item": "https://questionsmedicales.fr/mesh/D010860"
},
{
"@type": "ListItem",
"position": 4,
"name": "Porphyrines",
"item": "https://questionsmedicales.fr/mesh/D011166"
},
{
"@type": "ListItem",
"position": 5,
"name": "Uroporphyrines",
"item": "https://questionsmedicales.fr/mesh/D014578"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Uroporphyrines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Uroporphyrines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Uroporphyrines",
"description": "Comment diagnostiquer une accumulation d'uroporphyrines ?\nQuels tests sont utilisés pour évaluer les uroporphyrines ?\nQuels symptômes peuvent indiquer un excès d'uroporphyrines ?\nLes tests génétiques sont-ils nécessaires pour le diagnostic ?\nQuelle est l'importance de l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D014578?mesh_terms=Developing+Countries&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Uroporphyrines",
"description": "Quels sont les symptômes courants des troubles liés aux uroporphyrines ?\nLes uroporphyrines provoquent-elles des problèmes cutanés ?\nY a-t-il des symptômes psychologiques associés ?\nLes douleurs abdominales sont-elles fréquentes ?\nComment les symptômes varient-ils selon les individus ?",
"url": "https://questionsmedicales.fr/mesh/D014578?mesh_terms=Developing+Countries&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Uroporphyrines",
"description": "Comment prévenir les troubles liés aux uroporphyrines ?\nUne alimentation spécifique peut-elle aider ?\nLes examens réguliers sont-ils nécessaires ?\nLe stress influence-t-il les troubles des uroporphyrines ?\nLes vaccinations sont-elles importantes pour ces patients ?",
"url": "https://questionsmedicales.fr/mesh/D014578?mesh_terms=Developing+Countries&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Uroporphyrines",
"description": "Quels traitements sont disponibles pour les troubles des uroporphyrines ?\nLes transfusions sanguines sont-elles une option de traitement ?\nLa photothérapie est-elle efficace pour ces troubles ?\nLes médicaments peuvent-ils réduire les niveaux d'uroporphyrines ?\nY a-t-il des traitements alternatifs recommandés ?",
"url": "https://questionsmedicales.fr/mesh/D014578?mesh_terms=Developing+Countries&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Uroporphyrines",
"description": "Quelles complications peuvent survenir avec les uroporphyrines ?\nLes troubles hépatiques sont-ils une complication possible ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles réversibles ?\nLes complications psychologiques sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D014578?mesh_terms=Developing+Countries&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Uroporphyrines",
"description": "Quels sont les principaux facteurs de risque des troubles des uroporphyrines ?\nL'alcoolisme est-il un facteur de risque ?\nLes médicaments peuvent-ils augmenter le risque ?\nLes infections sont-elles un facteur de risque ?\nLe sexe influence-t-il le risque de troubles ?",
"url": "https://questionsmedicales.fr/mesh/D014578?mesh_terms=Developing+Countries&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une accumulation d'uroporphyrines ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic se fait par analyse d'urine pour mesurer les niveaux d'uroporphyrines."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les uroporphyrines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de laboratoire, comme l'électrophorèse, sont utilisés pour évaluer les uroporphyrines."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un excès d'uroporphyrines ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des douleurs abdominales et des troubles cutanés peuvent indiquer un excès."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils nécessaires pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests génétiques peuvent être nécessaires pour confirmer des troubles héréditaires."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier des facteurs de risque et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des troubles liés aux uroporphyrines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleurs abdominales, photosensibilité et troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les uroporphyrines provoquent-elles des problèmes cutanés ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent causer des éruptions cutanées et une sensibilité accrue au soleil."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes psychologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'anxiété et la dépression peuvent être associés à ces troubles."
}
},
{
"@type": "Question",
"name": "Les douleurs abdominales sont-elles fréquentes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les douleurs abdominales sont un symptôme fréquent des troubles des uroporphyrines."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon les individus ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent varier en fonction de la gravité et du type de trouble métabolique."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles liés aux uroporphyrines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les déclencheurs comme l'alcool et certains médicaments peut aider à prévenir les crises."
}
},
{
"@type": "Question",
"name": "Une alimentation spécifique peut-elle aider ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en glucides et faible en graisses peut aider à prévenir les symptômes."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils nécessaires ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à surveiller les niveaux d'uroporphyrines et prévenir les complications."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il les troubles des uroporphyrines ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut aggraver les symptômes et déclencher des crises chez certains patients."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes pour ces patients ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent prévenir des infections qui pourraient aggraver l'état de santé."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les troubles des uroporphyrines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des modifications diététiques et des médicaments pour gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Les transfusions sanguines sont-elles une option de traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les transfusions peuvent être utilisées dans certains cas pour traiter les complications."
}
},
{
"@type": "Question",
"name": "La photothérapie est-elle efficace pour ces troubles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La photothérapie peut aider à réduire les symptômes cutanés liés à la photosensibilité."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils réduire les niveaux d'uroporphyrines ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent aider à réduire les niveaux d'uroporphyrines dans le corps."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs recommandés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements alternatifs comme l'acupuncture peuvent être envisagés pour soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les uroporphyrines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des lésions cutanées, des douleurs chroniques et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les troubles hépatiques sont-ils une complication possible ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles hépatiques peuvent survenir en raison de l'accumulation d'uroporphyrines."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent réduire la qualité de vie en provoquant douleur et incapacité fonctionnelle."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non."
}
},
{
"@type": "Question",
"name": "Les complications psychologiques sont-elles fréquentes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications psychologiques comme l'anxiété peuvent survenir en raison de la maladie."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque des troubles des uroporphyrines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies hépatiques et des expositions environnementales."
}
},
{
"@type": "Question",
"name": "L'alcoolisme est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'alcoolisme peut aggraver les symptômes et augmenter le risque de complications."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils augmenter le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent déclencher des crises chez les personnes sensibles."
}
},
{
"@type": "Question",
"name": "Les infections sont-elles un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent exacerber les symptômes et augmenter le risque de complications."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque de troubles ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains troubles des uroporphyrines sont plus fréquents chez les femmes que chez les hommes."
}
}
]
}
]
}
In every society, there exist disadvantaged groups who have failed constantly to take part in the development of the economy and reap the benefits of economic growth as well. Along with economic and s...
No single method of health technology assessment (HTA) can meet all the policy- and decision-making needs in a country. However, there should be minimum criteria for performing HTA worldwide, and many...
This study aimed to assess the quality of HTA reports in the Islamic Republic of Iran....
We examined all the HTA research reports published by the Iranian HTA office up to 2020, using the International Network of Agencies for Health Technology Assessment checklist for quality assessment....
A total of 97 reports were examined, of which only 10.0% provided complete and appropriate contact details for further information and 5.6% clearly stated a conflict of interest. In 87.78% of the repo...
We recommend that minimum standards be established for the HTA process so that healthcare policy- and decision-makers can make reliable decisions on the basis of the HTA reports....
Air pollution is a major challenge faced by most countries due to the continuous quest of industrialization leading to a high pollution, which Africa is not an exception. Nowadays countries are trying...
Previous studies have reported a high frequency of vitamin D deficiency (VDD) among different age groups in Iran....
In this study, the current coverage, status of vitamin D supplement taking, and program efficacy have been evaluated by the Office of Nutrition Department Society in Iran since 2014....
This study was conducted in collaboration with the International UNESCO center for Health-Related Basic Sciences and Human Nutrition and the Office of Nutrition Department Society. Sixty three medical...
Quantitative analysis showed that availability coverage was 74.96% and 77.56% and accessibility was 80.70% and 83.26% in elderly and middle-aged subjects, respectively in 2018. The acceptability was a...
The frequency of taking vitamin D supplements was 27.0% in Iran in 2018. The frequency of taking of vitamin D supplements among vitamin D deficient group (serum vitamin D levels <19.99 ng/ml) was 43.6...
Vaccine hesitancy is proving to be a significant impediment to COVID-19 vaccination campaigns in some developing countries. This study focuses on vaccine hesitancy and means of reducing it. Data come ...
Pelonomi Tertiary Hospital is the only hospital in the Free State Province with a burns unit. We do not have official data to assess our performance in the management of burns....
To determine the Lethal Area 50 (LA50) index for the Pelonomi Tertiary Hospital's burns unit. Furthermore, to determine the morbidity that affects burns patients at the institution, and the factors as...
We used Redcap to capture demographic and clinical data of burn patients admitted to our institution between January 2014 and December 2018. Logistic regression was used to determine significant predi...
Our study had a male preponderance, with 59.7% (601) male, 39.9% (401) female and 0.4% (4) missing sex. We had a mean age of 19.4 years, of which 53.38% (n=537) were paediatric patients and 46.32% (n=...
The epidemiology of burn patients and working conditions at Pelonomi Tertiary Hospital are similar to other burn units in the country; however, our mortality rate is higher than at most centres. The L...
Technical aspects of inguinoscrotal herniorrhaphy performed in low to middle income countries (LMICs) are described here to help surgeons who will operate on these challenging hernias in austere setti...
Technical considerations related to operative repair were delineated with the consensus of 7 surgeons with extensive experience in inguinoscrotal hernia repair in LMICs. Important steps and illustrati...
The authors have cumulatively performed over 1775 inguinoscrotal Lichtenstein operations in LMICs. While dedicated, reliable, long-term follow-up is unavailable from LMICs, one author reports outcomes...
There is a difference between inguinal hernias found in LMICs and those seen in high-income countries with larger, chronic, and more technically challenging pathology. The consequences of intra-operat...
Growing populations, expanding economies, industrialisation, and urbanisation pose a problem for waste management in developing countries. Their waste management methods, on the other hand, are not as...
Considering the relevant role played by women in agriculture in Africa, this study sets out to examine how women's engagement in agriculture contributes to human capital development in selected Africa...
With increasing trend of internet use in all age groups, whether internet use can prevent frailty in middle-aged and older adults remains unclear....
Five cohorts, including Health and Retirement Study (HRS), China Health and Retirement Longitudinal Study (CHARLS), the Survey of Health, Ageing and Retirement in Europe (SHARE), English Longitudinal ...
In the multicohort study, a total of 155,695 participants were included in main analysis. The proportion of internet use was varied across countries, ranging from 5.56% in China (CHARLS) to 83.46% in ...
Our findings highlight the important role of internet use in preventing frailty and recommend more engagements in social communication and activities to avoid social isolation among middle-aged and ol...